Kensey Nash originally developed Angio-Seal, and St. Jude bought the marketing and manufacturing rights for the device from Tyco International in early 1999. "Angio-Seal will now be marketed by one of ...

Recently published results from the Cardiovascular and Interventional Radiological Society of Europe (“CIRSE”) vascular closure device registry further validated the safety and efficacy of medical ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Results from a Cordis analysis presented at the 14 th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) congress in Madrid indicates ...

Procedures involving use of a collagen plug-based vascular closure device rarely led to the onset of critical limb ischemia, according to results of a new study. Researchers retrospectively ...

For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

CHICAGO, IL–Use of a large-bore vascular closure device tested in patients undergoing transcatheter aortic valve replacement and endovascular aortic repair procedures appears to be safe and effective ...

Co announces regulatory approval from the Ministry of Health, Labor and Welfare, in addition to reimbursement approval, for the angio-seal STS plus Vascular closure device. U.S. President Joe Biden ...

En route to Abbott’s acquisition of St. Jude Medical, the duo is agreeing to sell off portions of their vascular and electrophysiology units, worth about $1.12 billion, to Terumo. The transaction is ...

Prior to the inception of percutaneous arterial closure devices, small-sheath size arterial puncture sites were managed with manual compression, which is labor intensive and requires a health care ...